Skip to content

Clinical trials

Phase 1/2 Immune System Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 1/2 Country / region: Spain Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20171
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2
Celgene1
Curis, Inc.1
Novartis Pharmaceuticals1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases6
Lymphatic Diseases3
Lymphoma3
Lymphoma, Non-Hodgkin3
Lymphoproliferative Disorders3
Immunoproliferative Disorders2
Neoplasms2
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.